Understanding the Biology of Human Interstitial Cells of Cajal in Gastrointestinal Motility

Int J Mol Sci. 2020 Jun 25;21(12):4540. doi: 10.3390/ijms21124540.

Abstract

Millions of patients worldwide suffer from gastrointestinal (GI) motility disorders such as gastroparesis. These disorders typically include debilitating symptoms, such as chronic nausea and vomiting. As no cures are currently available, clinical care is limited to symptom management, while the underlying causes of impaired GI motility remain unaddressed. The efficient movement of contents through the GI tract is facilitated by peristalsis. These rhythmic slow waves of GI muscle contraction are mediated by several cell types, including smooth muscle cells, enteric neurons, telocytes, and specialised gut pacemaker cells called interstitial cells of Cajal (ICC). As ICC dysfunction or loss has been implicated in several GI motility disorders, ICC represent a potentially valuable therapeutic target. Due to their availability, murine ICC have been extensively studied at the molecular level using both normal and diseased GI tissue. In contrast, relatively little is known about the biology of human ICC or their involvement in GI disease pathogenesis. Here, we demonstrate human gastric tissue as a source of primary human cells with ICC phenotype. Further characterisation of these cells will provide new insights into human GI biology, with the potential for developing novel therapies to address the fundamental causes of GI dysmotility.

Keywords: ICC; bioinformatics; gastrointestinal motility; human; interstitial cells of Cajal; molecular characterisation; mouse; peristalsis; pluripotent stem cells..

Publication types

  • Review

MeSH terms

  • Gastrointestinal Diseases / metabolism
  • Gastrointestinal Motility / physiology*
  • Gastrointestinal Tract / physiology
  • Humans
  • Interstitial Cells of Cajal / metabolism*
  • Interstitial Cells of Cajal / pathology*
  • Intestine, Small
  • Myocytes, Smooth Muscle
  • Peristalsis
  • Stomach